Joint with: Obesity Therapeutics: Unlocking Benefits and Minimizing Side Effects
Cardiometabolism in Health and Disease

Jan 26–29, 2026 | Keystone Resort, Keystone, CO, United States
Scientific Organizers: Daniel P. Kelly, Rong Tian and William C. Sessa

  Livestream
  In Person
  On Demand
 Add to Calendar

Jan 26–29, 2026 | Keystone Resort, Keystone, CO, United States
Scientific Organizers: Daniel P. Kelly, Rong Tian and William C. Sessa

Supported by the  Directors' Fund

***Meeting program subject to change.

Available Formats:     = Livestream   = In Person     = On Demand
Monday, January 26, 2026
Registration
4:00–8:00 PM
Welcome Mixer
6:00–8:00 PM
Tuesday, January 27, 2026
On Own for Lunch
12:15–2:30 PM
Breakfast
7:00–8:00 AM
Welcome and Keynote Address (Joint)
8:00–9:00 AM
Richard D DiMarchi, Indiana University
The Chemical Evolution of Peptides To Transform Human Health
Beyond Weight Loss: New Directions for Obesity Therapeutics (Joint)
9:00–11:15 AM
Rachel J. Roth Flach, Pfizer Inc.
Targeting Metabolism for HFpEF
Susan Quaggin, Northwestern University
A United Vision for Kidney and Cardiovascular Disease Treatment
James Trevaskis, Eli Lilly
Incretins for MASH Treatment
Short Talk(s) Chosen from Abstracts
Coffee Break
9:30–9:50 AM
Meet the Editors (Joint)
11:15–12:15 PM
* Rong Tian, University of Washington
Poster Setup
11:15–1:00 PM
Poster Viewing
1:00–10:00 PM
Symposia Spotlight 1: Emerging Therapies, Lifestyle Interventions and AI Approaches
2:30–4:30 PM
Short Talk(s) Chosen from Abstracts
Coffee Available
4:30–5:00 PM
Metabolic Origins of Heart Health and Disease
5:00–7:00 PM
Daniel P. Kelly, University of Pennsylvania
Modulating Cardiac Maturation in the Failing Heart
Catherine Makarewich, Cincinnati Children's Hospital Medical Center
Microproteins as Targets in the Diseased Heart
David A. Kass, Johns Hopkins Hospital
Integrated OMIC and Physiologic Interrogation of HFpEF
Short Talk(s) Chosen from Abstracts
Social Hour with Dinner
7:00–8:00 PM
Posters
7:30–10:00 PM
Wednesday, January 28, 2026
Breakfast
7:00–8:00 AM
Metabolic Contributions to Vascular Health and Disease
8:00–11:00 AM
William C. Sessa, Pfizer
Probing Trans-Vascular Lipid Trafficking
Katrien De Bock, Swiss Federal Institute of Technology
Metabolic Determinants of Angiogenesis in Disease States
Yajaira Suarez, Yale School of Medicine
Regulators of Macrophage or Endothelial Cell Functions in Atherosclerosis
Zoltan Arany, University of Pennsylvania
Metabolic Determinants of Vascular Function
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
Poster Setup
11:00–1:00 PM
On Own for Lunch
11:00–3:00 PM
Poster Viewing
1:00–10:00 PM
Career Roundtable (Joint)
1:30–2:45 PM
Panel Discussion: SGLT2 and GLP-1: Potential Mechanisms of Cardioprotective Actions
3:00–4:30 PM
* Daniel P. Kelly, University of Pennsylvania
Coffee Available
4:30–5:00 PM
Mitochondria and Cardiometabolic Disease
5:00–7:00 PM
Rong Tian, University of Washington
Mitochondria in HFpEF
E. Dale Abel, David Geffen School of Medicine and UCLA Health
Mitochondrial Dynamics and Cardiometabolic Disease
Yibin Wang, Duke-NUS, Singapore
Branched-Chain Amino Acid Metabolism in the Failing Heart
Short Talk(s) Chosen from Abstracts
Social Hour with Dinner
7:00–8:00 PM
Posters
7:30–10:00 PM
Thursday, January 29, 2026
Breakfast
7:00–8:00 AM
Emerging Therapies for Obesity and Cardiometabolic Diseases (Joint)
8:00–11:00 AM
Matthias H. Tschöp, Helmholtz Munich
Dual and Triple Co-Agonists: From Discovery to Best-in-Class
Kirsten Raun, Novo Nordisk A/S
Amylin: The All-Inclusive Obesity Therapeutic
Thomas Alexander Lutz, University of Zürich
Amylin Physiology and its Therapeutic Potential to Treat Metabolic Diseases
Murielle M Véniant-Ellison, Amgen Inc.
Unlocking the Power of GIPR and GLP-1R Targeting for Effective Weight Loss and Metabolic Improvement
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
On Own for Lunch
11:00–2:30 PM
Symposia Spotlight 2: Leverage AI for Biomedical Research
2:30–4:30 PM
Short Talk(s) Chosen from Abstracts
Coffee Available
4:30–5:00 PM
Environmental and Social Modulators of CV Health and Disease
5:00–6:45 PM
Martin E. Young, University of Alabama at Birmingham
Circadian Control of the Heart in Health and Disease
Danica Chen, University of California, Berkeley
Aging and Cardiovascular Health
Tiffany Powell-Wiley, NHLBI, National Institutes of Health
Social Determinants of Obesity and Cardiovascular Risk
Short Talk(s) Chosen from Abstracts
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
6:45–7:00 PM
Social Hour with Dinner
7:00–8:00 PM
Cash Bar
8:00–11:00 PM
Entertainment
8:00–11:00 PM
Friday, January 30, 2026
Departure
12:00–11:59 PM

Subscribe for Updates